A.M. Moody

1.4k total citations
26 papers, 995 citations indexed

About

A.M. Moody is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, A.M. Moody has authored 26 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 9 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in A.M. Moody's work include Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (6 papers) and Advanced Radiotherapy Techniques (5 papers). A.M. Moody is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (6 papers) and Advanced Radiotherapy Techniques (5 papers). A.M. Moody collaborates with scholars based in United Kingdom and United States. A.M. Moody's co-authors include Charles B. Wilson, Charlotte E. Coles, N.G. Burnet, Gillian C. Barnett, Jennifer Wilkinson, N. Twyman, Gordon Wishart, Judith M. Bliss, John R. Owen and John Yarnold and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Neurology.

In The Last Decade

A.M. Moody

25 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Moody United Kingdom 15 648 405 308 238 229 26 995
Heidi Stranzl Austria 14 536 0.8× 161 0.4× 187 0.6× 264 1.1× 513 2.2× 29 1.1k
György Németh Hungary 17 1.0k 1.6× 586 1.4× 240 0.8× 470 2.0× 319 1.4× 71 1.4k
T Lingos United States 5 439 0.7× 216 0.5× 210 0.7× 235 1.0× 287 1.3× 9 756
Matthew M. Poggi United States 13 417 0.6× 213 0.5× 197 0.6× 320 1.3× 282 1.2× 26 953
Yasmin Hasan United States 20 339 0.5× 383 0.9× 285 0.9× 306 1.3× 196 0.9× 56 1.1k
Margot Lehman Australia 19 341 0.5× 404 1.0× 272 0.9× 186 0.8× 324 1.4× 70 1.1k
Bethany Anderson United States 16 242 0.4× 155 0.4× 166 0.5× 174 0.7× 196 0.9× 48 738
Martin B. Levene United States 14 844 1.3× 268 0.7× 210 0.7× 513 2.2× 360 1.6× 28 1.5k
Kristine E. Kokeny United States 14 409 0.6× 92 0.2× 102 0.3× 260 1.1× 304 1.3× 40 812
James Butler Canada 15 149 0.2× 314 0.8× 203 0.7× 296 1.2× 138 0.6× 28 767

Countries citing papers authored by A.M. Moody

Since Specialization
Citations

This map shows the geographic impact of A.M. Moody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Moody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Moody more than expected).

Fields of papers citing papers by A.M. Moody

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Moody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Moody. The network helps show where A.M. Moody may publish in the future.

Co-authorship network of co-authors of A.M. Moody

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Moody. A scholar is included among the top collaborators of A.M. Moody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Moody. A.M. Moody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Higgs, Brandon W., et al.. (2018). AB1212 Analytical validation of an interferon-inducible gene expression kit as a potential diagnostic test for anifrolumab. Annals of the Rheumatic Diseases. 77. 1704–1705. 1 indexed citations
2.
Mukesh, M., Wendi Qian, J. Wilkinson, et al.. (2016). The Cambridge Breast Intensity-modulated Radiotherapy Trial: Comparison of Clinician- versus Patient-reported Outcomes. Clinical Oncology. 28(6). 354–364. 19 indexed citations
3.
Mukesh, Mukesh B., Wendi Qian, Jennifer Wilkinson, et al.. (2014). Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: Results from the Cambridge Breast IMRT trial. Radiotherapy and Oncology. 111(2). 270–275. 30 indexed citations
4.
Corrie, Pippa, A.M. Moody, Santi Nolasco, et al.. (2013). Is community treatment best? a randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery. British Journal of Cancer. 109(6). 1549–1555. 27 indexed citations
5.
Corrie, Pippa, Charles B. Wilson, Simon Bond, et al.. (2012). A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications. British Journal of Cancer. 107(4). 585–587. 27 indexed citations
6.
Mukesh, M., Gillian C. Barnett, Jennifer Wilkinson, et al.. (2012). Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: Results from the Cambridge Breast IMRT trial. European Journal of Surgical Oncology. 38(10). 918–924. 36 indexed citations
7.
Barnett, Gillian C., Jennifer Wilkinson, A.M. Moody, et al.. (2011). The Cambridge Breast Intensity-modulated Radiotherapy Trial: Patient- and Treatment-related Factors that Influence Late Toxicity. Clinical Oncology. 23(10). 662–673. 63 indexed citations
8.
Barnett, Gillian C., Jennifer Wilkinson, A.M. Moody, et al.. (2011). Randomized Controlled Trial of Forward-Planned Intensity Modulated Radiotherapy for Early Breast Cancer: Interim Results at 2 Years. International Journal of Radiation Oncology*Biology*Physics. 82(2). 715–723. 86 indexed citations
9.
Zandi, Michael S., Sarosh R. Irani, George Follows, et al.. (2009). LIMBIC ENCEPHALITIS ASSOCIATED WITH ANTIBODIES TO THE NMDA RECEPTOR IN HODGKIN LYMPHOMA. Neurology. 73(23). 2039–2040. 55 indexed citations
10.
Coles, C.E., Gillian C. Barnett, J. Wilkinson, et al.. (2009). A Randomised Controlled Trial of Forward-Planned Intensity Modulated Radiotherapy (IMRT) for Early Breast Cancer: Interim Results at 2 Years Follow-Up.. Cancer Research. 69(24_Supplement). 71–71. 6 indexed citations
11.
Coles, Charlotte E., A.M. Moody, Charles B. Wilson, & N.G. Burnet. (2005). Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Clinical Oncology. 17(2). 98–110. 39 indexed citations
12.
Coles, Charlotte E., A.M. Moody, Charles B. Wilson, & N.G. Burnet. (2004). Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Clinical Oncology. 17(1). 16–24. 44 indexed citations
13.
14.
Moody, A.M., et al.. (2001). British National Lymphoma Investigation: Pilot Studies of Neoadjuvant Chemotherapy in Clinical Stage Ia and IIa Hodgkin's Disease. Clinical Oncology. 13(4). 262–268. 11 indexed citations
15.
Moody, A.M., et al.. (1998). Were there metastases?. The Lancet. 351(9113). 1402–1402. 2 indexed citations
16.
Moody, A.M. & M.V. Williams. (1997). Radiation dose in Hodgkin's disease: Are we overtreating?. Clinical Oncology. 9(3). 155–157. 5 indexed citations
17.
Moody, A.M., John Sharpe, Cyril Fisher, & Clive Harmer. (1996). Medullary carcinoma of the thyroid misdiagnosed as differentiated thyroid carcinoma. Clinical Oncology. 8(4). 261–263. 4 indexed citations
18.
Moody, A.M., et al.. (1995). Renin-producing leiomyosarcoma originating in the uterus. Clinical Oncology. 7(1). 52–53. 5 indexed citations
19.
Moody, A.M., W. P. M. Mayles, Judith M. Bliss, et al.. (1994). The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiotherapy and Oncology. 33(2). 106–112. 225 indexed citations
20.
Moody, A.M., et al.. (1989). Florid radiological appearance of megakaryoblastic leukaemia — an aid to earlier diagnosis. Pediatric Radiology. 19(6-7). 486–488. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi Stranzl Breakdown of academic impact, for papers by György Németh Breakdown of academic impact, for papers by T Lingos Breakdown of academic impact, for papers by Matthew M. Poggi Breakdown of academic impact, for papers by Yasmin Hasan Breakdown of academic impact, for papers by Margot Lehman Breakdown of academic impact, for papers by Bethany Anderson Breakdown of academic impact, for papers by Martin B. Levene Breakdown of academic impact, for papers by Kristine E. Kokeny Breakdown of academic impact, for papers by James Butler
Rankless by CCL
2026